NVAX Stock Analysis: Buy, Sell, or Hold?
NVAX - Novavax Inc
$9.06
-0.29 (-3.10%)
▼
5d:
-10.39%
30d:
+4.86%
90d:
+4.14%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Smart Money Accumulation
NVAX is down 10.4% this week, but smart money is accumulating calls. Top strike: $9 2026-07-17 with 7,919 OI. Call ratio: 93% View Scanner →
Strength: 9.5/10
Get Alerted When NVAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
15 traders called NVAX this week
85% bullish • 4 bearish
85% bullish • 4 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NVAX is down 10.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NVAX is down 10.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NVAX is currently trading at $9.06, which is considered slightly high relative to its 30-day fair value range of $7.98 to $9.17. From a valuation perspective, the stock is trading at a discount (Forward PE: -50.2) compared to its historical average (35.1). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, NVAX is in a uptrend. Immediate support is located at $7.81, while resistance sits at $10.75. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: NVAX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.11 (+55.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NVAX is in a uptrend. Immediate support is located at $7.81, while resistance sits at $10.75. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: NVAX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.11 (+55.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$7.98 -
$9.17
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.4%
Protect Your Profits
Holding NVAX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 55.8% below Wall St target ($14.11)
- WARNING: Recommendation downgraded due to -10.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$7.98 -
$9.17
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$7.81
Resistance Level
$10.75
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-50.25
Wall Street Target
$14.11
(+55.8%)
Revenue Growth (YoY)
-79.1%
Earnings Growth (YoY)
-38.1%
Profit Margin
-14.7%
PE vs Historical
-50.3 vs 35.1
CHEAP
Share & Embed Analysis
Last updated: May 18, 2026 9:20 AM ET
Data refreshes hourly during market hours. Next update: 10:20 AM
Data refreshes hourly during market hours. Next update: 10:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVAX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 61 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 57 HOLD |
Advanced NVAX Option Strategies
Professional options setups generated by AI based on today's NVAX price and gamma walls.
